513 related articles for article (PubMed ID: 27782328)
1. More than complementing Tolls: complement-Toll-like receptor synergy and crosstalk in innate immunity and inflammation.
Hajishengallis G; Lambris JD
Immunol Rev; 2016 Nov; 274(1):233-244. PubMed ID: 27782328
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk pathways between Toll-like receptors and the complement system.
Hajishengallis G; Lambris JD
Trends Immunol; 2010 Apr; 31(4):154-63. PubMed ID: 20153254
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between complement and toll-like receptors.
Song WC
Toxicol Pathol; 2012; 40(2):174-82. PubMed ID: 22109714
[TBL] [Abstract][Full Text] [Related]
4. Microbial hijacking of complement-toll-like receptor crosstalk.
Wang M; Krauss JL; Domon H; Hosur KB; Liang S; Magotti P; Triantafilou M; Triantafilou K; Lambris JD; Hajishengallis G
Sci Signal; 2010 Feb; 3(109):ra11. PubMed ID: 20159852
[TBL] [Abstract][Full Text] [Related]
5. The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis.
Hovland A; Jonasson L; Garred P; Yndestad A; Aukrust P; Lappegård KT; Espevik T; Mollnes TE
Atherosclerosis; 2015 Aug; 241(2):480-94. PubMed ID: 26086357
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between toll-like receptors and hypoxia-dependent pathways in health and disease.
Crifo B; Taylor CT
J Investig Med; 2016 Feb; 64(2):369-75. PubMed ID: 26247129
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network.
Chinenov Y; Rogatsky I
Mol Cell Endocrinol; 2007 Sep; 275(1-2):30-42. PubMed ID: 17576036
[TBL] [Abstract][Full Text] [Related]
8. Complement and dysbiosis in periodontal disease.
Hajishengallis G; Lambris JD
Immunobiology; 2012 Nov; 217(11):1111-6. PubMed ID: 22964237
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between complement and Toll-like receptor activation in relation to donor brain death and renal ischemia-reperfusion injury.
Damman J; Daha MR; van Son WJ; Leuvenink HG; Ploeg RJ; Seelen MA
Am J Transplant; 2011 Apr; 11(4):660-9. PubMed ID: 21446970
[TBL] [Abstract][Full Text] [Related]
10. Regulation of B cell functions by Toll-like receptors and complement.
Kremlitzka M; Mácsik-Valent B; Erdei A
Immunol Lett; 2016 Oct; 178():37-44. PubMed ID: 27485187
[TBL] [Abstract][Full Text] [Related]
11. RAGE and TLRs: relatives, friends or neighbours?
Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptors and integrins crosstalk.
Alhamdan F; Bayarsaikhan G; Yuki K
Front Immunol; 2024; 15():1403764. PubMed ID: 38915411
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptors in human papillomavirus infection.
Zhou Q; Zhu K; Cheng H
Arch Immunol Ther Exp (Warsz); 2013 Jun; 61(3):203-15. PubMed ID: 23435874
[TBL] [Abstract][Full Text] [Related]
14. Self, non-self, and danger: a complementary view.
Köhl J
Adv Exp Med Biol; 2006; 586():71-94. PubMed ID: 16893066
[TBL] [Abstract][Full Text] [Related]
15. Complement takes its Toll: an inflammatory crosstalk between Toll-like receptors and the receptors for the complement anaphylatoxin C5a.
Holst B; Raby AC; Hall JE; Labéta MO
Anaesthesia; 2012 Jan; 67(1):60-64. PubMed ID: 22150483
[TBL] [Abstract][Full Text] [Related]
16. The complement system, toll-like receptors and inflammasomes in host defense: three musketeers' one target.
Kumar V
Int Rev Immunol; 2019; 38(4):131-156. PubMed ID: 31066339
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase networks that limit TLR signalling.
Clark K
Biochem Soc Trans; 2014 Feb; 42(1):11-24. PubMed ID: 24450622
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory pathways in malaria infection: TLRs share the stage with other components of innate immunity.
Erdman LK; Finney CA; Liles WC; Kain KC
Mol Biochem Parasitol; 2008 Dec; 162(2):105-11. PubMed ID: 18804125
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity.
Kawai T; Akira S
Immunity; 2011 May; 34(5):637-50. PubMed ID: 21616434
[TBL] [Abstract][Full Text] [Related]
20. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
